Parag Shah
Plus aucun poste en cours
Fortune : 1 359 $ au 30/04/2024
Historique de carrière de Parag Shah
Anciens postes connus de Parag Shah
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Directeur des opérations | 01/04/2016 | 31/08/2023 |
| IKARIA, INC. | Corporate Officer/Principal | 01/01/2012 | - |
Formation de Parag Shah
| Carnegie Mellon University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Bourse
- Insiders
- Parag Shah
- Expérience
